SANUWAVE, Inc. Health Announces European Launch of OrthoPACE(TM) Regenerative Medicine Device for Orthopedic Indications

ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTCBB: SNWV), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports the European launch of the orthoPACE™ device intended for use in orthopedic, trauma and sports medicine indications following CE mark approval last month.